LIMITS OF STEM-CELL THERAPIES
Tags: STEM cells -- Therapeutic use; EMBRYONIC stem cells; THERAPEUTICS; MEDICINE -- Research; IMMUNE system
Related Articles
- Blastocyst Brouhaha. Bailey, Ronald // Reason;Oct2001, Vol. 33 Issue 5, p25
Addresses the issues concerning embryonic stem cell research in the United States. Diseases which are potential for treatment by stem cells; Scientific explanation on how the stem cells may be of therapeutic use; Argument on the cloning issue related to the implementation of the research;...
- Research. // Spectroscopy;Jun2008, Vol. 23 Issue 6, p13
The article reports on the potential of embryonic stem cell therapies to enhance cell differentiation. A new research work shows that the delivery of molecules within aggregates of embryonic stem cells through biodegradable microspheres enhances the efficiency and purity of differentiation. The...
- A Bipartisan Push for More Lines. Rosenberg, Debra; Kalb, Claudia // Newsweek;5/17/2004, Vol. 143 Issue 20, p10
Focuses on efforts to increase stem-cell research in the United States. Number of stem-cell lines that are ready for use; Efforts of legislators to seek bipartisan support for expanding federal funding; Comments from Representative Duke Cunningham regarding the potential benefits of stem-cell...
- Adult Stem Cells--Real Hope for the Future, Real Help for Patients Now. Prentice, David A. // National Right to Life News;Jan2011, Vol. 38 Issue 1, p5
This article looks forward to the future of research on embryonic stem cell. It criticizes embryonic stem cell research for not helping a single patient. It also offers an overview of three experimental trials approved in the U.S. that propose to utilize derivatives of embryonic stem cells to...
- Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Atlantic Edition);11/8/2004, Vol. 144 Issue 19, p54
Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...
- Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Pacific Edition);11/8/2004, Vol. 144 Issue 19, p46
Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...
- Human Embryonic Stem Cell Therapies for Neurodegenerative Diseases. Tomaskovic-Crook, Eva; Crook, Jeremy M. // CNS & Neurological Disorders - Drug Targets;Jun2011, Vol. 10 Issue 4, p440
There is a renewed enthusiasm for the clinical translation of human embryonic stem (hES) cells. This is abetted by putative clinically-compliant strategies for hES cell maintenance and directed differentiation, greater understanding of and accessibility to cells through formal cell registries...
- Stem Cell Tourism. Cook, Michael // Australasian Science;Oct2011, Vol. 32 Issue 8, p48
The article discusses the issue whether stem cells can be used as a therapy for diabetes and hair loss. It notes the cases in which bovine cells or unsorted tissue slurries from human fetal brain are given by unscrupulous clinics to patients. It clarifies that scientists badly sold stem cells to...
- The persistence of memory. // Nature Medicine;Oct2010, Vol. 16 Issue 10, p1082
The article presents insights from Alan Trounson, Martin Pera, and Shinya Yamanaka on the use of induced pluripotent stem cells (iPSCs) that carry epigenetic memory in therapy and drug development. Trounson states that the epigenetic memory carried by iPSCs must be studied to prevent phenotypic...
